Stephen J. Gwyther
Surrey and Sussex Healthcare NHS Trust · 63 works · 33,856 citations · h-index 20
Top works
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- Evaluation of lymph nodes with RECIST 1.1
- Lessons learned from independent central review
- RECIST 1.1—Update and clarification: From the RECIST committee
- Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
- Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
- RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
- Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)
- Pulmonary embolism, pulmonary hypertension, and choriocarcinoma
- Modern techniques in radiological imaging related to oncology
- Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group
- PRACTICAL USE OF DUPLEX DOPPLER ANALYSIS OF THE RENAL VASCULATURE IN CRITICALLY ILL PATIENTS
- Response assessment using radiological methods
- Noninvasive monitoring of renal blood flow characteristics during acute renal failure in man
- RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis
- Results of an independent oncology review board of pivotal clinical trials of gemcitabine in non-small cell lung cancer
- Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer
- Interpretation of duplex Doppler ultrasound in renal transplants in the early postoperative period
- How to assess anti-tumour efficacy by imaging techniques
- A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)